Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma

Clinical trial NCT07377045 · RECRUITING

Trial details

NCT number: NCT07377045
Sponsor: Oncomatryx Biopharma S.L.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma Metastatic

Start date: 2025-10-28
Primary completion: 2029-03-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.